No abstract available.
Kumar A. CB-0821, a novel CC chemokine receptor 5 (CCR5) inhibitor with improved binding efficacy proposed as anti-HIV candidate: Computational and in vitro approach. Biotechnology and applied biochemistry. 2024 Aug;71(4):849-859
PMID: 0
View Full Text